Your browser doesn't support javascript.
loading
Targeting a novel bone degradation pathway in primary bone cancer by inactivation of the collagen receptor uPARAP/Endo180.
Engelholm, Lars H; Melander, Maria C; Hald, Andreas; Persson, Morten; Madsen, Daniel H; Jürgensen, Henrik J; Johansson, Kristina; Nielsen, Christoffer; Nørregaard, Kirstine S; Ingvarsen, Signe Z; Kjaer, Andreas; Trovik, Clement S; Laerum, Ole D; Bugge, Thomas H; Eide, Johan; Behrendt, Niels.
Affiliation
  • Engelholm LH; Finsen Laboratory/Biotech Research and Innovation Centre (BRIC), Rigshospitalet and University of Copenhagen, Denmark.
  • Melander MC; Finsen Laboratory/Biotech Research and Innovation Centre (BRIC), Rigshospitalet and University of Copenhagen, Denmark.
  • Hald A; Finsen Laboratory/Biotech Research and Innovation Centre (BRIC), Rigshospitalet and University of Copenhagen, Denmark.
  • Persson M; Department of Clinical Physiology, Nuclear Medicine and PET and Cluster for Molecular Imaging, Rigshospitalet and University of Copenhagen, Denmark.
  • Madsen DH; Proteases and Tissue Remodelling Section, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, MD, USA.
  • Jürgensen HJ; Finsen Laboratory/Biotech Research and Innovation Centre (BRIC), Rigshospitalet and University of Copenhagen, Denmark.
  • Johansson K; Finsen Laboratory/Biotech Research and Innovation Centre (BRIC), Rigshospitalet and University of Copenhagen, Denmark.
  • Nielsen C; Finsen Laboratory/Biotech Research and Innovation Centre (BRIC), Rigshospitalet and University of Copenhagen, Denmark.
  • Nørregaard KS; Finsen Laboratory/Biotech Research and Innovation Centre (BRIC), Rigshospitalet and University of Copenhagen, Denmark.
  • Ingvarsen SZ; Finsen Laboratory/Biotech Research and Innovation Centre (BRIC), Rigshospitalet and University of Copenhagen, Denmark.
  • Kjaer A; Department of Clinical Physiology, Nuclear Medicine and PET and Cluster for Molecular Imaging, Rigshospitalet and University of Copenhagen, Denmark.
  • Trovik CS; Department of Oncology/Orthopaedics, Haukeland University Hospital, Bergen, Norway.
  • Laerum OD; Finsen Laboratory/Biotech Research and Innovation Centre (BRIC), Rigshospitalet and University of Copenhagen, Denmark.
  • Bugge TH; Department of Clinical Medicine, Gade Laboratory of Pathology, University of Bergen, Norway.
  • Eide J; Proteases and Tissue Remodelling Section, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, MD, USA.
  • Behrendt N; Department of Pathology, Haukeland University Hospital, Bergen, Norway.
J Pathol ; 238(1): 120-33, 2016 Jan.
Article in En | MEDLINE | ID: mdl-26466547
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Osteolysis / Bone Neoplasms / Receptors, Mitogen / Osteosarcoma Type of study: Etiology_studies / Prognostic_studies Limits: Animals / Humans Language: En Journal: J Pathol Year: 2016 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Osteolysis / Bone Neoplasms / Receptors, Mitogen / Osteosarcoma Type of study: Etiology_studies / Prognostic_studies Limits: Animals / Humans Language: En Journal: J Pathol Year: 2016 Document type: Article Affiliation country: Country of publication: